Metabolic liver disease - what you need to know and do: Metabolic risks including central obesity, raised blood pressure and hyperglycaemia are now recognised as major contributing factors in the development of liver disease, which is itself a risk factor for cardiovascular disease

The article explores the growing prevalence of metabolic liver disease, specifically focusing on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic Associated Steatotic Hepatitis (MASH), and Metabolic Alcohol-Related Liver Disease (MetALD). It highlights that metabolic risks such as central obesity, high blood pressure, and hyperglycemia significantly contribute to liver disease, which has become the third leading cause of death in the UK.